References
- Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr 2006;43:413-27. https://doi.org/10.1097/01.mpg.0000239995.58388.56
- Hubscher SG. Histological assessment of non-alcoholic fatty liver disease. Histopathology 2006;49:450-65. https://doi.org/10.1111/j.1365-2559.2006.02416.x
- Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes (Lond) 2008;32:381-7. https://doi.org/10.1038/sj.ijo.0803711
- Srinivasan S, Ogle GD, Garnett SP, Briody JN, Lee JW, Cowell CT. Features of the metabolic syndrome after childhood craniopharyngioma. J Clin Endocrinol Metab 2004;89:81-6. https://doi.org/10.1210/jc.2003-030442
- Adams LA, Feldstein A, Lindor KD, Angulo P. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. Hepatology 2004;39:909-14. https://doi.org/10.1002/hep.20140
- Lee HH, Byun YH, Shin WY, Kim SH, Song MH, Jo YJ, et al. A case of cryptogenic liver cirrhosis with hypopituitarism. Korean J Intern Med 2007;72:116-20.
- Altuntas B, Ozcakar B, Bideci A, Cinaz P. Cirrhotic outcome in patients with craniopharyngioma. J Pediatr Endocrinol Metab 2002;15:1057-8.
- Basenau D, Stehphani U, Fischer G. Development of complete liver cirrhosis in hyperphagia-induced fatty liver. Klin Padiatr 1994;206:62-4. https://doi.org/10.1055/s-2008-1046584
- Takano S, Kanzaki S, Sato M, Kubo T, Seino Y. Effect of growth hormone on fatty liver in panhypopituitarism. Arch Dis Child 1997;76:537-8. https://doi.org/10.1136/adc.76.6.537
- Nakajima K, Hashimoto E, Kaneda H, Tokushige K, Shiratori K, Hizuka N, et al. Pediatric nonalcoholic steatohepatitis associated with hypopituitarism. J Gastroenterol 2005;40:312-5. https://doi.org/10.1007/s00535-004-1541-4
- Park JY, Ko JS, Seo JK, Lee R, Shin CH, Kang GH, et al. Nonalcoholic fatty liver disease progressing to cirrhosis in an obese boy with hypopituitarism. Koean J Gastroenterol Nutr 2008;11:204-9.
- Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-74. https://doi.org/10.1111/j.1572-0241.1999.01377.x
- Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, Burghen GA, et al. Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 2003;88:611-6. https://doi.org/10.1210/jc.2002-021180
- Muller HL, Bueb K, Bartels U, Roth C, Harz K, Graf N, et al. Obesity after childhood craniopharyngioma--German multicenter study on pre-operative risk factors and quality of life. Klin Padiatr 2001;213:244-9. https://doi.org/10.1055/s-2001-16855
- Johansson JO, Fowelin J, Landin K, Lager I, Bengtsson BA. Growth hormone-deficient adults are insulin-resistant. Metabolism 1995;44:1126-9. https://doi.org/10.1016/0026-0495(95)90004-7
- Hwu CM, Kwok CF, Lai TY, Shih KC, Lee TS, Hsiao LC, et al. Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GHdeficient adults: a report of one-year clinical experience. J Clin Endocrinol Metab 1997;82:3285-92. https://doi.org/10.1210/jc.82.10.3285
- Kaji H, Sakurai T, Iguchi G, Murata M, Kishimoto M, Yoshioka S, et al. Adult growth hormone deficiency in Japan: results of investigation by questionnaire. Endocr J 2002;49:597-604. https://doi.org/10.1507/endocrj.49.597
- Ko JS, Yoon JM, Yang HR, Myung JK, Kim HR, Kang GH, et al. Clinical and histological features of nonalcoholic fatty liver disease in children. Dig Dis Sci 2009;54:2225-30. https://doi.org/10.1007/s10620-009-0949-3
- Loria P, Carulli L, Bertolotti M, Lonardo A. Endocrine and liver interaction: the role of endocrine pathways in NASH. Nat Rev Gastroenterol Hepatol 2009;6:236-47. https://doi.org/10.1038/nrgastro.2009.33
- Lonardo A, Loria P, Leonardi F, Ganazzi D, Carulli N. Growth hormone plasma levels in nonalcoholic fatty liver disease. Am J Gastroenterol 2002;97:1071-2. https://doi.org/10.1111/j.1572-0241.2002.05641.x
- Ichikawa T, Hamasaki K, Ishikawa H, Ejima E, Eguchi K, Nakao K. Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency. Gut 2003;52:914. https://doi.org/10.1136/gut.52.6.914
- Fukuda I, Hizuka N, Yasumoto K, Morita J, Kurimoto M, Takano K. Metabolic co-morbidities revealed in patients with childhood-onset adult GH deficiency after cessation of GH replacement therapy for short stature. Endocr J 2008;55:977-84. https://doi.org/10.1507/endocrj.K08E-079
- Takahashi Y, Iida K, Takahashi K, Yoshioka S, Fukuoka H, Takeno R, et al. Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency. Gastroenterology 2007;132:938-43. https://doi.org/10.1053/j.gastro.2006.12.024
- Evans LM, Davies JS, Anderson RA, Ellis GR, Jackson SK, Lewis MJ, et al. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency. Eur J Endocrinol 2000;142:254-62. https://doi.org/10.1530/eje.0.1420254
- Liangpunsakul S, Chalasani N. Is hypothyroidism a risk factor for non-alcoholic steatohepatitis? J Clin Gastroenterol 2003;37:340-3. https://doi.org/10.1097/00004836-200310000-00014